← Back to Analyst Consensus 
ZLAB Buy
Zai Lab Ltd
Current Price —
Implied Upside —
Analysts 14
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 7, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 8, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Mar 18, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Feb 27, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | $37 | 50% |
| Feb 5, 2026 | JP Morgan | maintain | Overweight → Overweight | $39 | 54% |
| Jan 7, 2026 | UBS | initiate | — → Buy | $35 | 54% |
| Aug 11, 2025 | Citigroup | maintain | Buy → Buy | $69 | 54% |
| Jun 30, 2025 | Leerink Partners | maintain | Outperform → Outperform | $75 | 51% |
| Mar 27, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $0 | 50% |
| Mar 13, 2025 | JP Morgan | maintain | Overweight → Overweight | $51 | 54% |
| Mar 7, 2025 | Scotiabank | initiate | — → Sector Outperform | $55 | 55% |
| Mar 3, 2025 | B of A Securities | downgrade | Buy → Neutral | $36.1 | 53% |
| Oct 25, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Oct 21, 2024 | JP Morgan | maintain | Overweight → Overweight | $44 | 54% |
| Aug 7, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Jul 12, 2024 | JP Morgan | maintain | Overweight → Overweight | $38 | 54% |
| Jul 1, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Jun 25, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Feb 29, 2024 | Citigroup | maintain | Buy → Buy | $66 | 54% |
| Dec 14, 2023 | Morgan Stanley | initiate | — → Overweight | $47.5 | 54% |
| Nov 30, 2023 | JP Morgan | maintain | Overweight → Overweight | $66 | 54% |
| Oct 26, 2023 | Citigroup | maintain | Buy → Buy | $128 | 54% |
| Oct 26, 2023 | Goldman Sachs | maintain | Buy → Buy | $73.34 | 54% |
| Oct 17, 2023 | JP Morgan | maintain | Overweight → Overweight | $64 | 54% |
| Oct 9, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $70 | 50% |
| Sep 18, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $70 | 50% |
| Aug 10, 2023 | Cantor Fitzgerald | initiate | — → Overweight | $70 | 50% |
| Jun 12, 2023 | B of A Securities | maintain | — → Buy | $62.5 | 53% |
| May 11, 2023 | Citigroup | maintain | Buy → Buy | $130 | 54% |
| Mar 16, 2023 | JP Morgan | maintain | — → Overweight | $70 | 54% |
| Nov 18, 2022 | JP Morgan | maintain | — → Overweight | $79 | 54% |
| Nov 11, 2022 | Citigroup | maintain | — → Buy | $127 | 54% |
| Aug 9, 2022 | Citigroup | maintain | — → Buy | $199 | 54% |
| May 12, 2022 | Citigroup | maintain | — → Buy | $193 | 54% |
| May 11, 2022 | SVB Leerink | maintain | — → Outperform | $95 | — |
| Apr 21, 2022 | SVB Leerink | maintain | — → Outperform | $101 | — |
| Apr 4, 2022 | JP Morgan | maintain | — → Overweight | $112 | 54% |
| Mar 2, 2022 | SVB Leerink | maintain | — → Outperform | $102 | — |
| Dec 15, 2021 | JP Morgan | maintain | — → Overweight | $136 | 54% |
| Nov 11, 2021 | Citigroup | maintain | — → Buy | $217 | 54% |
| Nov 10, 2021 | SVB Leerink | maintain | — → Outperform | $194 | — |
| Oct 12, 2021 | Bernstein | initiate | — → Market Perform | $0 | 52% |
| Jun 1, 2021 | SVB Leerink | maintain | — → Outperform | $202 | — |
| Apr 14, 2021 | SVB Leerink | maintain | — → Outperform | $192 | — |
| Feb 3, 2021 | SVB Leerink | maintain | — → Outperform | $189 | — |
| Sep 10, 2020 | SVB Leerink | maintain | — → Outperform | $95 | — |
| Dec 30, 2019 | Citigroup | maintain | — → Buy | $84 | 54% |
| Sep 4, 2019 | China Renaissance | initiate | — → Buy | $0 | 58% |
| Jul 5, 2019 | Macquarie | initiate | — → Outperform | $0 | 56% |
| Jan 29, 2019 | Credit Suisse | initiate | — → Outperform | $34.7 | — |
Price Target Trend
Jul 3, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days